📰 Aldx News
Page 2 - Aldx News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Aldx. Real-time updates on events, politics, business and more.
October 9, 2023
StockNews.com began coverage on shares of Aldeyra Therapeutics (NASDAQ:ALDX – Free Report) in a report released on Thursday. The brokerage issued a sell rating on the biotechnology company’s stock. Other equities research analysts have also issued reports about the company. Oppenheimer reissued an outperform rating and issued a $14.00 price target on shares of Aldeyra […]
October 4, 2023
Aldeyra Therapeutics, Inc (NASDAQ:ALDX – Get Free Report) was the recipient of a significant growth in short interest in September. As of September 15th, there was short interest totalling 6,450,000 shares, a growth of 5.9% from the August 31st total of 6,090,000 shares. Based on an average trading volume of 646,300 shares, the short-interest ratio […]
September 28, 2023
Shares of Aldeyra Therapeutics, Inc (NASDAQ:ALDX – Get Free Report) passed below its 50 day moving average during trading on Monday . The stock has a 50 day moving average of $7.42 and traded as low as $5.95. Aldeyra Therapeutics shares last traded at $6.15, with a volume of 583,139 shares traded. Analyst Ratings Changes […]
September 20, 2023
StockNews.com lowered shares of Aldeyra Therapeutics (NASDAQ:ALDX – Free Report) from a hold rating to a sell rating in a report issued on Sunday. A number of other research firms have also commented on ALDX. Oppenheimer reaffirmed an outperform rating and issued a $14.00 price objective on shares of Aldeyra Therapeutics in a research note […]
September 20, 2023
StockNews.com cut shares of Aldeyra Therapeutics (NASDAQ:ALDX – Free Report) from a hold rating to a sell rating in a report released on Sunday morning. Other analysts also recently issued research reports about the company. HC Wainwright reissued a buy rating and issued a $15.00 price objective on shares of Aldeyra Therapeutics in a research […]
September 19, 2023
NEW YORK, Sept. 19, 2023 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Aldeyra...
September 13, 2023
StockNews.com upgraded shares of Aldeyra Therapeutics (NASDAQ:ALDX – Free Report) from a sell rating to a hold rating in a research report sent to investors on Saturday. Other equities research analysts also recently issued reports about the stock. HC Wainwright reiterated a buy rating and set a $15.00 price objective on shares of Aldeyra Therapeutics […]
September 11, 2023
Aldeyra Therapeutics (NASDAQ:ALDX – Get Free Report) was upgraded by investment analysts at StockNews.com from a “sell” rating to a “hold” rating in a report released on Saturday. ALDX has been the subject of a number of other reports. HC Wainwright reissued a “buy” rating and issued a $15.00 price target on shares of Aldeyra […]
September 7, 2023
Prosight Management LP decreased its holdings in Aldeyra Therapeutics, Inc (NASDAQ:ALDX – Free Report) by 55.3% in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 383,447 shares of the biotechnology company’s stock after selling 475,262 shares during the quarter. Aldeyra Therapeutics makes up about […]
September 5, 2023
StockNews.com lowered shares of Aldeyra Therapeutics (NASDAQ:ALDX – Free Report) from a hold rating to a sell rating in a report published on Friday morning. A number of other equities analysts have also recently weighed in on ALDX. Oppenheimer reaffirmed an outperform rating and set a $14.00 price target on shares of Aldeyra Therapeutics in […]